SFX by Ex Libris Inc.

Title:	Leptin and diabetes in lipoatrophic mice
Source:	Nature [0028-0836] Gavrilova, Oksana yr:2000

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	"Gut hormones and Type 2 diabetes mellitus." Diabetes management. 4.6: 501-513.
description	2.	Reitman, M L L. "A-ZIP/F-1 mice lacking white fat: a model for understanding lipoatrophic diabetes." International journal of obesity 24 Suppl 4.S4: 11-4.
description	3.	"Gut hormones and diabetes." Diabetes research and clinical practice 5 (1988).
description	4.	Ducy, P. "Leptin Inhibits Bone Formation through a Hypothalamic Relay." Cell 100.2 (2000): 197-207.
description	5.	W., Stephen Waring S. "Antidiabetic drugs." Medicine 35.11 (2012): 98-99.
description	6.	Lamarre, Neil S. "Effect of obese and lean Zucker rat sera on human and rat prostate cancer cells: implications in obesity-related prostate tumor biology." Urology 69.1 (2007): 191-5.
description	7.	Arita, Y. "Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity." Biochemical and biophysical research communications 257.1 (1999): 79-83.
description	8.	Leibel, R L L. "Effects of gender, body composition, and menopause on plasma concentrations of leptin." The Journal of clinical endocrinology & metabolism 81.9 (1996): 3424-7.
description	9.	Hotta, K. "Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients." Arteriosclerosis, thrombosis, and vascular biology 20.6 (2000): 1595-9.
description	10.	Yamauchi, T. "The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity." Nature medicine 7.8 (2001): 941-6.
description	11.	Bell, Christopher G G. "The genetics of human obesity." Nature reviews. Genetics 6.3 (2005): 221-234.
description	12.	Reactions Weekly 1760.1 (2019): 26-26.
description	13.	"How many oral antidiabetic drugs before insulin?" Indian journal of endocrinology and metabolism 21.1: 249-250.
description	14.	BALLAND, E. "Hypothalamic Tanycytes Are an ERK-Gated Conduit for Leptin into the Brain." Cell metabolism 19.2 (2014): 293-301.
description	15.	Seck, Thomas L. "Sitagliptin more effectively achieves a composite endpoint for A1C reduction, lack of hypoglycemia and no body weight gain compared with glipizide." Diabetes research and clinical practice 93.1 (2011): 15-7.
description	16.	Flier, Jeffrey S S. "Physiology: is brain sympathetic to bone?" Nature 420.6916 (2002): 619-22.
description	17.	Aburto, A M. "The influence of vitamin A on the utilization and amelioration of toxicity of cholecalciferol, 25-hydroxycholecalciferol, and 1,25 dihydroxycholecalciferol in young broiler chickens." Poultry Science 77.4 (1998): 585-593.
description	18.	Graveling, Alex J. "Hypoglycaemia: An overview." Primary care diabetes 3.3 (2009): 131-9.
description	19.	KHEMAWOOT, P. "Obesity-induced increase of CYP 2 E 1 activity and its effect on disposition kinetics of chlorzoxazone in Zucker rats." Biochemical Pharmacology 73.1 (2007): 155-162.
description	20.	Rowden, A. "Emergency Management of Oral Hypoglycemic Drug Toxicity." Emergency medicine clinics of North America 25.2 (2007): 347-356.